Swiss Bitcoin Pay, a bitcoin payment processor based in Switzerland, temporarily shut down its servers after a data breach exposed customer email addresses, bitcoin addresses, IBANs, transaction history, and hashed passwords. The company confirmed that user funds are safe and any owed amounts will be fully returned. This incident adds to a series of recent breaches affecting bitcoin and fintech firms, highlighting ongoing security challenges in the crypto industry. Swiss Bitcoin Pay is investigating and securing its infrastructure to prevent further unauthorized access.
Swiss Bitcoin Pay's recent data breach is a notable event in the crypto space. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Sep 15, 2026 03:26 WIB: Out of 50 major cryptocurrencies, 33 rose and 16 fell today. Balancer (BAL) gained 11.14% to Rp16.297, Ripple (XRP) rose 9.67% to Rp26.191 with a buy order activity of 66%, and Stellar (XLM) increased 8.83% to Rp3.440 with 59% buy orders.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
